Shuxuening injection
- Generic Name
- Shuxuening injection
Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY)
Phase 3
Recruiting
- Conditions
- Ischemic Stroke, Acute
- Interventions
- Other: Placebo
- First Posted Date
- 2023-12-05
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- Beijing Tiantan Hospital
- Target Recruit Count
- 1380
- Registration Number
- NCT06157502
- Locations
- 🇨🇳
Wuchuan Gelao and Miao Autonomous County Hospital of Traditional Chinese Medicine, Zunyi, Guizhou, China
🇨🇳Wuchang Hospital of Traditional Chinese Medicine, Harbin, Heilongjiang, China
🇨🇳Pingdingshan First People's Hospital, Pingdingshan, Henan, China
Multi-modality MRI Study on Effect to Collateral Circulation and Blood Perfusion of Acute Cerebral Infarction by Human Urinary Kallidinogenase
Phase 2
Completed
- Conditions
- Cerebral Infarction
- Interventions
- First Posted Date
- 2014-10-08
- Last Posted Date
- 2014-10-08
- Lead Sponsor
- XuanwuH 2
- Target Recruit Count
- 120
- Registration Number
- NCT02259738
- Locations
- 🇨🇳
Department of Neurolgy,Xuanwu Hospital of Capital Medical University, Beijing, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath